Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score

World Journal of Gastroenterology

Volumn 21, Issue 25, 2015, Pages 7637-7647

  Kim, Hee Yeon ^a   Jang, Jeong Won ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Liver cirrhosis; Model for end stage liver diseases score; Mortality; Prognosis; Sarcopenia

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; GRAFT SURVIVAL; HUMAN; LIVER CIRRHOSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; MUSCLE FUNCTION; MUSCULOSKELETAL SYSTEM EXAMINATION; NUTRITIONAL ASSESSMENT; PATHOGENESIS; POSTOPERATIVE PERIOD; PREDICTION; PREVALENCE; PROGNOSTIC ASSESSMENT; SARCOPENIA; SEX DIFFERENCE; TREATMENT OUTCOME; DECISION SUPPORT SYSTEM; DISEASE COURSE; HEALTH STATUS INDICATOR; NUTRITIONAL STATUS; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; SKELETAL MUSCLE;

DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; HEALTH STATUS INDICATORS; HUMANS; LIVER CIRRHOSIS; MUSCLE, SKELETAL; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SARCOPENIA;

EID: 84936792379     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i25.7637     Document Type: Article

References (69)

1. Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet 2014;383:1749-1761 [PMID: 24480518 DOI: 10.1016/s0140-6736 (14) 60121-5]
2. Periyalwar P, Dasarathy S. Malnutrition in cirrhosis: contribution and consequences of sarcopenia on metabolic and clinical responses. Clin Liver Dis 2012;16:95-131 [PMID: 22321468 DOI: 10.1016/j.cld.2011.12.009]
3. Johnson TM, Overgard EB, Cohen AE, Di Baise JK. Nutrition assessment and management in advanced liver disease. Nutr Clin Pract 2013;28:15-29 [PMID: 23319353 DOI: 10.1177/08845336 12469027]
4. Juakiem W, Torres DM, Harrison SA. Nutrition in cirrhosis and chronic liver disease. Clin Liver Dis 2014;18:179-190 [PMID: 24274873 DOI: 10.1016/j.cld.2013.09.004]
5. O'Brien A, Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology 2008;134:1729-1740 [PMID: 18471550 DOI: 10.1053/j.gastro.2008.02.001]
6. Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014;20:8061-8071 [PMID: 25009378 DOI: 10.3748/wjg.v20.i25.8061]
7. Durand F, Buyse S, Francoz C, Laouénan C, Bruno O, Belghiti J, Moreau R, Vilgrain V, Valla D. Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography. J Hepatol 2014;60:1151-1157 [PMID: 24607622 DOI: 10.1016/j.jhep. 2014.02.026]
8. Hanai T, Shiraki M, Nishimura K, Ohnishi S, Imai K, Suetsugu A, Takai K, Shimizu M, Moriwaki H. Sarcopenia impairs prognosis of patients with liver cirrhosis. Nutrition 2015;31:193-199 [PMID: 25441595 DOI: 10.1016/j.nut.2014.07.005]
9. Kim TY, Kim MY, Sohn JH, Kim SM, Ryu JA, Lim S, Kim Y. Sarcopenia as a useful predictor for long-term mortality in cirrhotic patients with ascites. J Korean Med Sci 2014;29:1253-1259 [PMID: 25246744 DOI: 10.3346/jkms.2014.29.9.1253]
10. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, Sawyer MB. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012;10:166-173, 173.e1 [PMID: 21893129 DOI: 10.1016/j.cgh.2011.08.028]
11. Tandon P, Ney M, Irwin I, Ma MM, Gramlich L, Bain VG, Esfandiari N, Baracos V, Montano-Loza AJ, Myers RP. Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value. Liver Transpl 2012;18:1209-1216 [PMID: 22740290 DOI: 10.1002/lt.23495]
12. Montano-Loza AJ, Meza-Junco J, Prado CMM, Baracos VE, Sawyer MB, Beaumont C, Ma M, Kneteman N, Myers RP. Inclusion of sarcopenia within MELD (MELD-Sarcopenia) and the prediction of mortality in patients with cirrhoiss. Hepatology 2013;58 Suppl: 1041A
13. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649 [PMID: 4541913 DOI: 10.1002/bjs.1800600817]
14. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores-where are we and where should we go? J Hepatol 2004;41:344-350 [PMID: 15288486 DOI: 10.1016/j.jhep. 2004.06.005]
15. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871 [PMID: 10733541 DOI: 10.1053/he.2000.5852]
16. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470 [PMID: 11172350 DOI: 10.1053/jhep. 2001.22172]
17. Botta F, Giannini E, Romagnoli P, Fasoli A, Malfatti F, Chiarbonello B, Testa E, Risso D, Colla G, Testa R. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut 2003;52:134-139 [PMID: 12477775 DOI: 10.1136/gut.52.1.134]
18. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96 [PMID: 12512033 DOI: 10.1053/gast.2003.50016]
19. Huo TI, Lee SD, Lin HC. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008;28:606-613 [PMID: 18433390 DOI: 10.1111/j.1478-3231.2008.01727.x]
20. Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management. J Hepatol 2003;38 Suppl 1:S69-S89 [PMID: 12591187]
21. Heuman DM, Abou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, Fisher RA, Mihas AA. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810 [PMID: 15382176 DOI: 10.1002/hep. 20405]
22. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026 [PMID: 18768945 DOI: 10.1056/NEJMoa0801209]
23. Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, Lee FY, Lee SD. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int 2007;27:498-506 [PMID: 17403190 DOI: 10.1111/j.1478-3231.2007.01445.x]
24. Leise MD, Kim WR, Kremers WK, Larson JJ, Benson JT, Therneau TM. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation. Gastroenterology 2011;140:1952-1960 [PMID: 21334338 DOI: 10.1053/j.gastro.2011.02.017]
25. Myers RP, Shaheen AA, Faris P, Aspinall AI, Burak KW. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One 2013;8:e51926 [PMID: 23349678 DOI: 10.1371/journal.pone.0051926]
26. Alvares-Da-Silva MR, Reverbel Da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition 2005;21:113-117 [PMID: 15723736 DOI: 10.1016/j.nut.2004.02.002]
27. Gunsar F, Raimondo ML, Jones S, Terreni N, Wong C, Patch D, Sabin C, Burroughs AK. Nutritional status and prognosis in cirrhotic patients. Aliment Pharmacol Ther 2006;24:563-572 [PMID: 16827812 DOI: 10.1111/j.1365-2036.2006.03003.x]
28. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007;85:1257-1266 [PMID: 17490961]
29. Sobhonslidsuk A, Roongpisuthipong C, Nantiruj K, Kulapongse S, Songchitsomboon S, Sumalnop K, Bussagorn N. Impact of liver cirrhosis on nutritional and immunological status. J Med Assoc Thai 2001;84:982-988 [PMID: 11759979]
30. Francoz C, Prié D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010;16:1169-1177 [PMID: 20879015 DOI: 10.1002/lt.22128]
31. Thuluvath PJ, Triger DR. Evaluation of nutritional status by using anthropometry in adults with alcoholic and nonalcoholic liver disease. Am J Clin Nutr 1994;60:269-273 [PMID: 8030606]
32. Horber FF, Thomi F, Casez JP, Fonteille J, Jaeger P. Impact of hydration status on body composition as measured by dual energy X-ray absorptiometry in normal volunteers and patients on haemodialysis. Br J Radiol 1992;65:895-900 [PMID: 1422663]
33. Madden AM, Morgan MY. The potential role of dual-energy X-ray absorptiometry in the assessment of body composition in cirrhotic patients. Nutrition 1997;13:40-45 [PMID: 9058447]
34. Pirlich M, Schütz T, Spachos T, Ertl S, Weiss ML, Lochs H, Plauth M. Bioelectrical impedance analysis is a useful bedside technique to assess malnutrition in cirrhotic patients with and without ascites. Hepatology 2000;32:1208-1215 [PMID: 11093726 DOI: 10.1053/jhep. 2000.20524]
35. Chinn KS, Hannon JP. Relationship of muscle protein to other components of the fat-free mass. Am J Physiol 1966;211:993-997 [PMID: 5926591]
36. Fiore P, Merli M, Andreoli A, De Lorenzo A, Masini A, Ciuffa L, Valeriano V, Balotta MT, Riggio O. A comparison of skinfold anthropometry and dual-energy X-ray absorptiometry for the evaluation of body fat in cirrhotic patients. Clin Nutr 1999;18:349-351 [PMID: 10634919 DOI: 10.1054/clnu.1999.0048]
37. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S. Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol (1985) 2004;97:2333-2338 [PMID: 15310748 DOI: 10.1152/japplphysiol.00744.2004]
38. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985) 1998;85:115-122 [PMID: 9655763]
39. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008;33:997-1006 [PMID: 18923576 DOI: 10.1139/h08-075]
40. Di Martini A, Cruz RJ, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Kim KH, Fontes P. Muscle mass predicts outcomes following liver transplantation. Liver Transpl 2013;19:1172-1180 [PMID: 23960026 DOI: 10.1002/lt.23724]
41. Englesbe MJ, Patel SP, He K, Lynch RJ, Schaubel DE, Harbaugh C, Holcombe SA, Wang SC, Segev DL, Sonnenday CJ. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010;211:271-278 [PMID: 20670867 DOI: 10.1016/j.jamcollsurg.2010.03.039]
42. Krell RW, Kaul DR, Martin AR, Englesbe MJ, Sonnenday CJ, Cai S, Malani PN. Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl 2013;19:1396-1402 [PMID: 24151041 DOI: 10.1002/lt.23752]
43. Meza-Junco J, Montano-Loza AJ, Baracos VE, Prado CM, Bain VG, Beaumont C, Esfandiari N, Lieffers JR, Sawyer MB. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013;47:861-870 [PMID: 23751844 DOI: 10.1097/MCG.0b013e318293a825]
44. Montano-Loza AJ. Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation. Curr Opin Clin Nutr Metab Care 2014;17:219-225 [PMID: 24613858 DOI: 10.1097/mco.0000000000000046]
45. Montano-Loza AJ, Meza-Junco J, Baracos VE, Prado CM, Ma M, Meeberg G, Beaumont C, Tandon P, Esfandiari N, Sawyer MB, Kneteman N. Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation. Liver Transpl 2014;20:640-648 [PMID: 24678005 DOI: 10.1002/lt.23863]
46. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, Garry PJ, Lindeman RD. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998;147:755-763 [PMID: 9554417 DOI: 10.1093/oxfordjournals.aje.a009520]
47. Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 2003;58:M911-M916 [PMID: 14570858]
48. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-423 [PMID: 20392703 DOI: 10.1093/ageing/afq034]
49. Lang T, Streeper T, Cawthon P, Baldwin K, Taaffe DR, Harris TB. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010;21:543-559 [PMID: 19779761 DOI: 10.1007/s00198-009-1059-y]
50. Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008;9:629-635 [PMID: 18539529 DOI: 10.1016/S1470-2045 (08) 70153-0]
51. Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 2013;31:1539-1547 [PMID: 23530101 DOI: 10.1200/JCO.2012.45.2722]
52. Montano-Loza AJ, Meza-Junco J, Prado CMM, Tandon P, Bain VG, Ma M, Beaumont C, Estandiari N, Sawyer MB, Baracos VE. New cutoff values for sarcopenia for predicting 6-month mortality in cirrhotic patients. J Hepatol 2013;58 Suppl: S95
53. Quigley EM. Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited. Dig Dis Sci 1996;41:557-561 [PMID: 8617136]
54. Kalaitzakis E, Bosaeus I, Ohman L, Björnsson E. Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure. Am J Clin Nutr 2007;85:808-815 [PMID: 17344504]
55. Le Moine O, Marchant A, De Groote D, Azar C, Goldman M, Devière J. Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology 1995;22:1436-1439 [PMID: 7590660]
56. Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis: its relationship to circulating micronutrients and food preferences. Hepatology 1997;26:40-48 [PMID: 9214450 DOI: 10.1002/hep. 510260106]
57. Bergheim I, Parlesak A, Dierks C, Bode JC, Bode C. Nutritional deficiencies in German middle-class male alcohol consumers: relation to dietary intake and severity of liver disease. Eur J Clin Nutr 2003;57:431-438 [PMID: 12627180 DOI: 10.1038/sj.ejcn. 1601557]
58. Amodio P, Caregaro L, Pattenò E, Marcon M, Del Piccolo F, Gatta A. Vegetarian diets in hepatic encephalopathy: facts or fantasies? Dig Liver Dis 2001;33:492-500 [PMID: 11572577]
59. Cheung K, Lee SS, Raman M. Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies. Clin Gastroenterol Hepatol 2012;10:117-125 [PMID: 21893127 DOI: 10.1016/j.cgh.2011.08.016]
60. Cruz RJ, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Fontes P, Di Martini A. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 2013;95:617-622 [PMID: 23348896 DOI: 10.1097/TP.0b013e31827a0f27]
61. Cosquéric G, Sebag A, Ducolombier C, Thomas C, Piette F, Weill-Engerer S. Sarcopenia is predictive of nosocomial infection in care of the elderly. Br J Nutr 2006;96:895-901 [PMID: 17092379]
62. Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010;8:979-985 [PMID: 20621200 DOI: 10.1016/j.cgh.2010.06.024]
63. Wong CH, Weiss D, Sourial N, Karunananthan S, Quail JM, Wolfson C, Bergman H. Frailty and its association with disability and comorbidity in a community-dwelling sample of seniors in Montreal: a cross-sectional study. Aging Clin Exp Res 2010;22:54-62 [PMID: 19940555 DOI: 10.3275/6675]
64. Masuda T, Shirabe K, Ikegami T, Harimoto N, Yoshizumi T, Soejima Y, Uchiyama H, Ikeda T, Baba H, Maehara Y. Sarcopenia is a prognostic factor in living donor liver transplantation. Liver Transpl 2014;20:401-407 [PMID: 24357065 DOI: 10.1002/lt.23811]
65. Montano-Loza AJ, Meza-Junco J, Prado CM, Baracos V, Sawyer M, Beaumont C, Ma MM, Kneteman N, Myers RP. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Hepatology 2013;58:1041A
66. Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, Tylavsky FA, Visser M, Newman AB. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006;61:1059-1064 [PMID: 17077199]
67. Riggio O, Angeloni S, Ciuffa L, Nicolini G, Attili AF, Albanese C, Merli M. Malnutrition is not related to alterations in energy balance in patients with stable liver cirrhosis. Clin Nutr 2003;22:553-559 [PMID: 14613758]
68. Carvalho L, Parise ER. Evaluation of nutritional status of nonhospitalized patients with liver cirrhosis. Arq Gastroenterol 2006;43:269-274 [PMID: 17406753]
69. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445-450 [PMID: 11399401]